These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34638814)

  • 1. The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism.
    Xu Y; Robev D; Saha N; Wang B; Dalva MB; Xu K; Himanen JP; Nikolov DB
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homotypic receptor-receptor interactions regulating Eph signaling.
    Nikolov DB; Xu K; Himanen JP
    Cell Adh Migr; 2014; 8(4):360-5. PubMed ID: 25530219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
    Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
    J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the EphB6 receptor ectodomain.
    Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
    PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain structures of Eph receptors.
    Himanen JP
    Semin Cell Dev Biol; 2012 Feb; 23(1):35-42. PubMed ID: 22044883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.
    Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P
    J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
    Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiam-Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion.
    Gaitanos TN; Koerner J; Klein R
    J Cell Biol; 2016 Sep; 214(6):735-52. PubMed ID: 27597758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
    Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
    J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eph/ephrin reverse signalling induces axonal retraction through RhoA/ROCK pathway.
    Takeuchi S; Katoh H; Negishi M
    J Biochem; 2015 Sep; 158(3):245-52. PubMed ID: 25922200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
    Nikolov DB; Xu K; Himanen JP
    Biochim Biophys Acta; 2013 Oct; 1834(10):2160-5. PubMed ID: 23628727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eph receptors and ephrins restrict cell intermingling and communication.
    Mellitzer G; Xu Q; Wilkinson DG
    Nature; 1999 Jul; 400(6739):77-81. PubMed ID: 10403252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphB2 regulates contact-dependent and contact-independent signaling to control platelet function.
    Vaiyapuri S; Sage T; Rana RH; Schenk MP; Ali MS; Unsworth AJ; Jones CI; Stainer AR; Kriek N; Moraes LA; Gibbins JM
    Blood; 2015 Jan; 125(4):720-30. PubMed ID: 25370417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J; Elowe S; Nash P; Pawson T
    J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent roles for Eph and ephrin in avian cranial neural crest.
    Mellott DO; Burke RD
    BMC Dev Biol; 2008 May; 8():56. PubMed ID: 18495033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
    Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.